Kuber Drugs Pvt.Ltd.
About Kuber Drugs Pvt.Ltd.
Data last updated:
Kuber Drugs Pvt.Ltd. was a private limited company based in Kolkata, West Bengal, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the financial services and investment segment of the financial services sector. It was incorporated on 14 December 1994.
The company was registered with the Registrar of Companies (ROC), Kolkata, under CIN U51397WB1994PTC066578.
The company had an authorised share capital of ₹57 Lakh and a paid-up capital of ₹56.84 Lakh. It was led by directors Abha Devi Agarwal and Nehal Agarwal.
Its last annual general meeting (AGM) was held on 29 December 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at Offic No. 803 41A A.J.C Bose Road Diamond Prestige 8th Floor, Kolkata, West Bengal, India – 700017.
As per the financials filed for FY 2021, the company reported a revenue of ₹36.63 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.53 Lakh (net margin 4.2%) and EBITDA of ₹1.72 Lakh (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 1% over five years.
Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it.
Company details
Contact details
Kuber Drugs Pvt.Ltd.'s registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffic No. 803 41A A.J.C Bose Road Diamond Prestige 8th Floor, Kolkata, West Bengal, India – 700017
- IndustryFinancial Services, Financial Activities
To see the full contact details of Kuber Drugs Pvt.Ltd., buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Kuber Drugs are trade and financial and insurance service. In detail, this covers wholesale trading and other financial activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| K | Financial and insurance Service | K8 | Other financial activities |
To see the full business activity and turnover split of Kuber Drugs Pvt.Ltd., buy the company report.
Financials of Kuber Drugs Pvt.Ltd.
FY 2021 filings availableKuber Drugs Pvt.Ltd. reported revenue of ₹36.63 Lakh (up 360% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 360% growth in the latest year. EBITDA fell 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 4.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kuber Drugs Pvt.Ltd., buy the company report.
Board of directors of Kuber Drugs Pvt.Ltd.
Kuber Drugs has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abha Devi Agarwal | Director | 22 Oct 2021 | 5 Years 0 Months | As last reported |
| Nehal Agarwal Also directs: Ekdant Enclave LLP | Director | 22 Dec 2021 | 4 Years 10 Months | As last reported |
Peer comparison
Kuber Drugs Pvt.Ltd. is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Beactive Pharmaceuticals Private Limited | ₹36.65 Lakh (FY 2024) | 85.0% | Ambala, Haryana, India | |||
| Hanni Fragrances Private Limited | ₹36.65 Lakh (FY 2025) | 6789.0% | Mumbai, Maharashtra, India | |||
| Windson Apparels Private Limited | ₹36.65 Lakh (FY 2015) | -63.0% | Kolkata, West Bengal, India | |||
| Paras Broking Private Limited | ₹36.65 Lakh (FY 2025) | -13.0% | Bhilwara, Rajasthan, India | |||
| Abh Business Alliance Hub Private Limited | ₹36.64 Lakh (FY 2025) | -54.0% | Kolkata, West Bengal, India | |||
| Kuber Drugs Pvt.Ltd.this company | ₹36.63 Lakh (FY 2021) | ₹1.53 Lakh | 4.2% | 360.0% | Kolkata, West Bengal, India | |
| Axis Ispat Private Limited | ₹36.63 Lakh (FY 2024) | 99.0% | New Delhi, Delhi, India | |||
| Rameshwaram Freelancers Private Limited | ₹36.63 Lakh (FY 2025) | 28.0% | Kolkata, West Bengal, India | |||
| New Green India Bio Plantation Private Limited | ₹36.62 Lakh (FY 2025) | 39.0% | Orai, Uttar Pradesh, India | |||
| Indus Autowheels Private Limited | ₹36.62 Lakh (FY 2020) | -81.0% | Jammu, Jammu and Kashmir, India | |||
| Simply Media Solutions Private Limited | ₹36.62 Lakh (FY 2017) | -53.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Kuber Drugs Pvt.Ltd., buy the company report.
Auditor
Kuber Drugs Pvt.Ltd. is audited by MAHATO PRABIR & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MAHATO PRABIR & ASSOCIATES | FY 2017 | 325966E |
Shareholding
The shareholding of Kuber Drugs Pvt.Ltd. is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Kuber Drugs Pvt.Ltd., buy the company report.
Legal cases
Kuber Drugs Pvt.Ltd. has 3 court cases on record: 2 filed by Kuber Drugs, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 2 | 0 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Company petition | Filed against the company by Re : Network Industries Ltd -and- | Disposed |
| NCLT, Kolkata | Court case (C.P.(CAA)) | Filed by the company | Disposed |
| NCLT, Kolkata | Court case (C.A.(CAA)) | Filed by the company | Disposed |
To see the full case history of Kuber Drugs Pvt.Ltd., buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kuber Drugs Pvt.Ltd.; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Kuber Drugs has 3 associated companies. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Kuber Drugs Pvt.Ltd.; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kuber Drugs Pvt.Ltd. has 5 board changes on record since 2021: 2 appointments and 3 cessations. The latest: Ishan Agarwal ceased to be Director on 24 Dec 2021.
Frequently asked questions
Kuber Drugs has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Kuber Drugs was a private limited company based in Kolkata, West Bengal, India. The company worked in financial activities, within the financial services industry. It was incorporated on 14 December 1994 and is registered under CIN U51397WB1994PTC066578. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Kuber Drugs was incorporated on 14 December 1994. It is registered with the Registrar of Companies, Kolkata.
Kuber Drugs had 2 directors:
- Abha Devi Agarwal - Director
- Nehal Agarwal - Director
The CIN (Corporate Identification Number) of Kuber Drugs is U51397WB1994PTC066578. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Kuber Drugs is at Offic No. 803 41A A.J.C Bose Road Diamond Prestige 8th Floor, Kolkata, West Bengal, India – 700017.
The latest financial statements of Kuber Drugs on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 29 December 2021. Year-wise statements from 2015 are in the company report.
Kuber Drugs operated in the financial services industry, in the financial activities segment.
The peers of Kuber Drugs by revenue are Beactive Pharmaceuticals Private Limited, Hanni Fragrances Private Limited, Windson Apparels Private Limited, Paras Broking Private Limited, Abh Business Alliance Hub Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Kuber Drugs has 3 court cases on record: 2 filed by the company and 1 filed against it. Most are in the nclt.
Ishan Agarwal ceased to be Director on 24 Dec 2021. Nehal Agarwal was appointed as Director on 22 Dec 2021. Nehal Agarwal ceased to be Director on 23 Oct 2021. Kuber Drugs has 5 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
